Flecainide Therapy

Flecainide Therapy is a pharmacological treatment modality classified under antiarrhythmic therapy that employs the class Ic sodium channel blocker flecainide acetamide to suppress cardiac arrhythmias by selectively inhibiting myocardial fast sodium channels and thereby reducing conduction velocity in atrial and ventricular tissues.

550

Publications

33.4K

Citations

2.2K

Authors

698

Institutions

Publications per year

2017–2026

48

Authors

2.2K

  1. AJ
    A. John Camm

    St George's, University of London, United Kingdom

    17 publications · 788 citations

    14

    h-index

  2. RS
    R. S. Bexton

    St Bartholomew's Hospital, United Kingdom

    11 publications · 636 citations

    11

    h-index

  3. KJ
    Kevin J. Hellestrand

    St Bartholomew's Hospital, United Kingdom

    13 publications · 689 citations

    11

    h-index

  4. GJ
    Gordon J. Conard

    American Dental Association, United States

    10 publications · 727 citations

    10

    h-index

  5. JL
    Jeffrey L. Anderson

    University of Utah, United States

    9 publications · 1K citations

    9

    h-index

1–5 of 2.2K

Venues

  1. The American Journal of Cardiology

    72 publications · 5.2K citations

    42

    h-index

  2. Journal of the American College of Cardiology

    JACC · 25 publications · 2K citations

    24

    h-index

  3. Circulation

    19 publications · 3.3K citations

    19

    h-index

  4. Pacing and Clinical Electrophysiology

    PACE · 20 publications · 673 citations

    17

    h-index

  5. Heart Rhythm

    17 publications · 957 citations

    16

    h-index

1–5